Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

ClinicalTrials.gov ID: NCT05776277

Public ClinicalTrials.gov record NCT05776277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Two-stage, Randomized, Controlled Trial Comparing the Safety and Efficacy of Iltamiocel With Placebo in the Treatment of Female Participants With Chronic Fecal Incontinence and a History of Obstetric Anal Sphincter Injury (DigniFI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10\^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphincter injury. Half of the participants will receive iltamiocel (injections with cells) and the other half will receive placebo.

Study identification

NCT ID
NCT05776277
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cook MyoSite
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2024 (Actual)
Primary completion
Dec 2026 (Estimated)
Completion
Dec 2027 (Estimated)
Last update posted
Oct 20, 2026

2024 – 2027

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
UC San Diego Health La Jolla California 92122 —
UC Irvine Medical Center Orange California 92868 —
University of California, San Francisco - Center for Colorectal Surgery San Francisco California 94158 —
Prestige Medical Group Tustin California 92780 —
American Association of Female Pelvic Medicine Westlake Village California 91361 —
University of Florida Shands Hospital Gainesville Florida 32610 —
Healthcare Clinical Data, Inc. Miami Florida 33161 —
Orlando Health Colon & Rectal Institute Orlando Florida 32806 —
USF Health South Tampa Center for Advanced Healthcare Tampa Florida 33606 —
Colorectal Wellness Center Fayetteville Georgia 30214 —
University of Illinois Chicago Illinois 60612 —
Franciscan Health Indianapolis Indianapolis Indiana 46237 —
Ochsner Health New Orleans Louisiana 70121 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Bennett Institute of Urogynecology and Incontinence Grand Rapids Michigan 49546 —
University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University School of Medicine St Louis Missouri 63110 —
Rutgers, Robert Wood Johnson Medical School, Clinical Research Center New Brunswick New Jersey 08901 —
Westchester Medical Center Hawthorne New York 10532 —
The Mount Sinai Medical Center New York New York 10029 —
Weill Cornell Medicine New York New York 10065 —
Stony Brook University Hospital Stony Brook New York 11794 —
Cleveland Clinic Main Campus Crile Building Cleveland Ohio 44195 —
Rhode Island Hospital Providence Rhode Island 02903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05776277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05776277 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →